{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:43:32Z","timestamp":1777329812081,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11096-020-01164-4","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T15:04:17Z","timestamp":1601564657000},"page":"566-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potentially inappropriate medications involved in drug\u2013drug interactions at hospital discharge in Croatia"],"prefix":"10.1007","volume":"43","author":[{"given":"Ivana","family":"Marinovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Ba\u010di\u0107 Vrca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Samard\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sre\u0107ko","family":"Maru\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivica","family":"Grgurevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"1164_CR1","unstructured":"World Health Organization. Transitions of care: technical series on safer primary care. Geneva: World Health Organization. 2016. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/252272\/9789241511599-eng.pdf?sequence=1&isAllowed=y. Accessed: 12 Sep 2020."},{"issue":"8","key":"1164_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2471\/BLT.17.198002","volume":"95","author":"A Sheikh","year":"2017","unstructured":"Sheikh A, Dhingra-Kumar N, Kelley E, Kieny MP, Donaldson JL. The third global patient safety challenge: tackling medication-related. Bull World Health Organ. 2017;95(8):546\u20136A.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"1164_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40801-018-0143-z","volume":"5","author":"RJG Arnold","year":"2018","unstructured":"Arnold RJG, Tang J, Schrecker J, Hild C. Impact of definitive drug\u2013drug interaction testing on medication management and patient care. Drugs Real World Outcomes. 2018;5(4):217\u201324.","journal-title":"Drugs Real World Outcomes"},{"issue":"11","key":"1164_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5414\/CPP38504","volume":"38","author":"GI K\u00f6hler","year":"2000","unstructured":"K\u00f6hler GI, Bode-B\u00f6ger SM, Busse R, Hoopmann M, Welte T, B\u00f6ger RH. Drug\u2013drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38(11):504\u201313.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"13","key":"1164_CR5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.289.13.1652","volume":"289","author":"DN Juurlink","year":"2003","unstructured":"Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug\u2013drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652\u20138.","journal-title":"JAMA"},{"issue":"9582","key":"1164_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","volume":"370","author":"L Mallet","year":"2007","unstructured":"Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185\u201391.","journal-title":"Lancet"},{"issue":"11","key":"1164_CR7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1345\/aph.1A484","volume":"36","author":"IK Bjorkman","year":"2002","unstructured":"Bjorkman IK, Fastbom J, Schmidt IK, Bernsten CB. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug\u2013drug interactions in the elderly. Ann Pharmacother. 2002;36(11):1675\u201381.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"1164_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107\u201316.","journal-title":"JAMA"},{"issue":"3","key":"1164_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1345\/aph.1R621","volume":"47","author":"J Doan","year":"2013","unstructured":"Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C. Prevalence and risk of potential cytochrome P450-mediated drug\u2013drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013;47(3):324\u201332.","journal-title":"Ann Pharmacother"},{"issue":"7559","key":"1164_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/bmj.333.7559.143","volume":"333","author":"RE Ferner","year":"2006","unstructured":"Ferner RE, Aronson JK. Communicating information about drug safety. BMJ. 2006;333(7559):143\u20135.","journal-title":"BMJ"},{"key":"1164_CR11","unstructured":"Eurostat. A look at the lives of the elderly in the EU today. Luxembourg: European Commission. 2017. Available at: https:\/\/ec.europa.eu\/eurostat\/cache\/infographs\/elderly\/index.html. Accessed: 13 Sep 2020."},{"issue":"7","key":"1164_CR12","first-page":"601","volume":"18","author":"C Palleria","year":"2013","unstructured":"Palleria C, Di Paolo A, Giofr\u00e8 C, Caglioti C, Leuzzi G, Siniscalchi A, et al. Pharmacokinetic drug\u2013drug interaction and their implication in clinical management. J Res Med Sci. 2013;18(7):601\u201310.","journal-title":"J Res Med Sci"},{"issue":"2","key":"1164_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0976-0105.134983","volume":"5","author":"PS Patel","year":"2014","unstructured":"Patel PS, Rana DA, Suthar JV, Malhotra SD, Patel VJ. A study of potential adverse drug\u2013drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital. J Basic Clin Pharm. 2014;5(2):44\u20138.","journal-title":"J Basic Clin Pharm"},{"issue":"9","key":"1164_CR14","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00228-013-1531-7","volume":"69","author":"S Marusic","year":"2013","unstructured":"Marusic S, Bacic-Vrca V, Obreli Neto PR, Franic M, Erdeljic V, Gojo-Tomic N. Actual drug\u2013drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. Eur J Clin Pharmacol. 2013;69(9):1717\u201324.","journal-title":"Eur J Clin Pharmacol"},{"issue":"20","key":"1164_CR15","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","volume":"73","author":"A Krishnaswami","year":"2019","unstructured":"Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, et al. Deprescribing in older adults with cardiovascular disease. J Am Coll Cardiol. 2019;73(20):2584\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1164_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827\u201334.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1164_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcp.12615","volume":"80","author":"L Morin","year":"2015","unstructured":"Morin L, Fastbom J, Laroche ML, Johnell K. Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates. Br J Clin Pharmacol. 2015;80(2):315\u201324.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1164_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00228-017-2246-y","volume":"73","author":"I Mucalo","year":"2017","unstructured":"Mucalo I, Had\u017eiabdi\u0107 MO, Brajkovi\u0107 A, Luki\u0107 S, Mari\u0107 P, Marinovi\u0107 I, et al. Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM List, STOPP Version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol. 2017;73(8):991\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1164_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00228-017-2218-2","volume":"73","author":"E S\u00f6nnerstam","year":"2017","unstructured":"S\u00f6nnerstam E, Sj\u00f6lander M, Gustafsson M. An Evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol. 2017;73(6):735\u201342.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1164_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s11096-019-00858-8","volume":"41","author":"LC Chiapella","year":"2019","unstructured":"Chiapella LC, Montemarani Menna J, Marzi M, Mamprin ME. Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List. Int J Clin Pharm. 2019;41(4):913\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1164_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1164_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"issue":"31\u201332","key":"1164_CR23","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31\u201332):543\u201351.","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"1164_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","volume":"71","author":"A Renom-Guiteras","year":"2015","unstructured":"Renom-Guiteras A, Meyer G, Th\u00fcrmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861\u201375.","journal-title":"Eur J Clin Pharmacol"},{"key":"1164_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/2042098619854014","author":"D Fialov\u00e1","year":"2019","unstructured":"Fialov\u00e1 D, Brki\u0107 J, Laffon B, Reissigov\u00e1 J, Gre\u0161\u00e1kov\u00e1 S, Dogan S, et al. Applicability of EU(7)-PIM criteria in cross-national studies in European countries. Ther Adv Drug Saf. 2019. https:\/\/doi.org\/10.1177\/2042098619854014.","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"1164_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jcpt.12494","volume":"42","author":"D Grina","year":"2017","unstructured":"Grina D, Briedis V. The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM List\u2014a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther. 2017;42(2):195\u2013200.","journal-title":"J Clin Pharm Ther"},{"key":"1164_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/0163278719900653","author":"M Stojanovi\u0107","year":"2020","unstructured":"Stojanovi\u0107 M, Vukovi\u0107 M, Jovanovi\u0107 M, Dimitrijevi\u0107 S, Radenkovi\u0107 M. Potentially inappropriate medications in nursing home residents: a comparison of two approaches [published online ahead of print, 2020 Jan 22]. Eval Health Prof. 2020. https:\/\/doi.org\/10.1177\/0163278719900653.","journal-title":"Eval Health Prof"},{"issue":"4","key":"1164_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-019-00847-x","volume":"41","author":"N Wamil","year":"2019","unstructured":"Wamil N, Mattsson S, Gustafsson M. Assessment of potentially inappropriate medications using the EU(7)-PIM list and the Swedish quality indicators. Int J Clin Pharm. 2019;41(4):903\u201312.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1164_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3109\/02813432.2012.712021","volume":"30","author":"K Frydenberg","year":"2012","unstructured":"Frydenberg K, Brekke M. Poor communication on patients\u2019 medication across health care levels leads to potentially harmful medication errors. Scand J Prim Health Care. 2012;30(4):234\u201340.","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"1164_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00228-017-2357-5","volume":"74","author":"WY Zheng","year":"2018","unstructured":"Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT. Drug\u2013drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15\u201327.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1164_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjopharm.2011.09.006","volume":"9","author":"H Zakrzewski-Jakubiak","year":"2011","unstructured":"Zakrzewski-Jakubiak H, Doan J, Lamoureux P, Singh D, Turgeon J, Tannenbaum C. Detection and prevention of drug\u2013drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software. Am J Geriatr Pharmacother. 2011;9(6):461\u201370.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"1164_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/02813432.2012.704813","volume":"30","author":"MS Bakken","year":"2012","unstructured":"Bakken MS, Ranhoff AH, Engeland A, Ruths S. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scand J Prim Health Care. 2012;30(3):169\u201375.","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"1164_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bcpt.13095","volume":"124","author":"I Ivanova","year":"2019","unstructured":"Ivanova I, Elseviers M, Wettermark B, Schmidt Mende K, Vander Stichele R, Christiaens T. Electronic assessment of cardiovascular potentially inappropriate medications in an administrative population database. Basic Clin Pharmacol Toxicol. 2019;124(1):62\u201373.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1164_CR34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2147\/CIA.S146009","volume":"12","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhou S, Pan K, Li X, Zhao X, Zhou Y, et al. Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria. Clin Interv Aging. 2017;12:1697\u2013703.","journal-title":"Clin Interv Aging"},{"issue":"7","key":"1164_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/FPC.0000000000000057","volume":"24","author":"L Gong","year":"2014","unstructured":"Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genomics. 2014;24(7):374\u201380.","journal-title":"Pharmacogenet Genomics"},{"key":"1164_CR36","unstructured":"Belupo. Moksonidin Belupo 0,4 mg: summary of product characteristics [online]. Available from: http:\/\/www.halmed.hr\/Lijekovi\/Baza-lijekova\/Moksonidin-Belupo-04-mg-filmom-oblozene-tablete\/9310\/. Accessed 13 Sep 2020."},{"issue":"39","key":"1164_CR37","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1093\/eurheartj\/ehz687","volume":"40","author":"PJ Grant","year":"2019","unstructured":"Grant PJ, Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: new features and the \u2018Ten Commandments\u2019 of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J. 2019;40(39):3215\u20137.","journal-title":"Eur Heart J"},{"issue":"2","key":"1164_CR38","first-page":"162","volume":"17","author":"EM Cornett","year":"2017","unstructured":"Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM. Medication-induced tardive dyskinesia: a review and update. Ochsner J. 2017;17(2):162\u201374.","journal-title":"Ochsner J"},{"key":"1164_CR39","unstructured":"GlaxoSmithKline. Ceftin (cefuroxime axetil): prescribing information [online]. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/050605s042lbl.pdf. Accessed: 12 Sep 2020."},{"issue":"3","key":"1164_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401\u20137.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"1164_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084\u201393.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1164_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/8755122518788809","volume":"34","author":"CM Ajimura","year":"2018","unstructured":"Ajimura CM, Jagan N, Morrow LE, Malesker MA. Drug interactions with oral inhaled medications. J Pharm Technol. 2018;34(6):273\u201380.","journal-title":"J Pharm Technol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01164-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:15:12Z","timestamp":1633050912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01164-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01164-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}